What is the Orange Healthcare ZAP-70 Test?
It is a specialised test that measures ZAP-70 protein expression, primarily in the context of evaluating chronic lymphocytic leukaemia (CLL).
Why is the Orange Healthcare ZAP-70 Test performed?
It is performed to help assess the prognosis of patients diagnosed with CLL and provide information about potential disease progression.
What condition is associated with the ZAP-70 Test?
The test is primarily associated with chronic lymphocytic leukaemia (CLL), a type of blood cancer affecting lymphocytes.
What sample is required for this test?
A peripheral blood sample is commonly used for ZAP-70 expression analysis, depending on the laboratorys testing protocol.
Is fasting required for the Orange Healthcare ZAP-70 Test?
Fasting is generally not required unless specifically instructed by the healthcare provider or laboratory.
What does increased ZAP-70 expression indicate?
Increased ZAP-70 expression in CLL cells may be associated with more aggressive disease characteristics and a potentially faster disease progression.
Is the ZAP-70 Test used to diagnose CLL?
No. The ZAP-70 test is not a standalone diagnostic test for CLL. Diagnosis generally involves blood cell analysis, immunophenotyping, and other clinical investigations.
Does a positive ZAP-70 result mean the disease will progress?
No. Increased ZAP-70 expression may indicate a higher-risk disease profile, but it does not determine the exact course of the disease. Results should be interpreted alongside other prognostic markers and clinical findings.